Meniscus Tear Market Growth Anticipated by 2032 | Major Players: Merck, Teva Pharmaceutical, Lipella Pharmaceuticals, Seikagaku Corporation

In the market landscape of Meniscus Tear, an impressive surge is expected during the study period spanning 2019 to 2032, according to latest report titled  “Meniscus Tear Market Insights, Epidemiology and Market Forecast 2032” from DelveInsight. 

The dynamics of the Meniscus Tear market is anticipated to change in the coming years owing to the rise in numbers of company’s taking interest in development of drugs for Meniscus Tear, improvement in the diagnosis, expected launch of emerging therapies during the forecast period.

The Meniscus Tear market report sheds light on Meniscus Tear current treatment practices, upcoming drugs in the Meniscus Tear pipeline, market shares of individual therapies, and the anticipated trajectory of the Meniscus Tear market size from 2019 to 2032 across the 7MM (the United States, the EU-4 comprising Italy, Spain, France, and Germany, the United Kingdom, and Japan).

Driving Forces Behind the Meniscus Tear Market Growth

The key driver for the surge in Meniscus Tear market size is the rise in number of incident/prevalent cases.

Discover the Anticipated Evolution and Growth of the Market @ Meniscus Tear Therapeutics Market Forecast

Therapeutic Advancements and Emerging Treatments:

• Meniscus Tear Clinical Trial Progression: The market is set to experience significant growth, driven by the progression of emerging therapies expected for launch between 2023 and 2032. Pioneering companies, including Smith & Nephew, Arcuro Medical, Zimmer Biomet Holdings, and others, are actively engaged in developing novel drugs for potential market entry.
• Meniscus Tear Innovative Therapies: Ongoing research and development activities are fostering the introduction of innovative devices designed to address the signs and symptoms of Meniscus Tear. Medical devices such as NOVOSTITCH PRO Meniscal Repair System, JuggarStitch, SuperBall meniscus repair system, and others are driving the Meniscus Tear market.

Meniscus Tear Market Dynamics

Smith & Nephew produced FAST-FIXm, a method for meniscal repair known for its robustness, consistency, and time-saving nature. Studies analyzing biomechanics have revealed that the vertical mattress suture accomplished with the FAST-FIX 360 Meniscal Repair System matches the biomechanical characteristics of a similar suture executed through open and inside-out repair techniques.

Moreover, in September 2020, Smith + Nephew introduced the NOVOSTITCH PRO Meniscal Repair System in Europe, following its successful acquisition of CE mark certification. This system broadens meniscal repair possibilities for approximately 600,000 European patients annually, who previously only had the option of removal. The NOVOSTITCH PRO Meniscal Repair System is commercially accessible in the US, Europe, Middle East, Africa, and selected countries.

In September 2019, Zimmer Biomet Holdings obtained clearance from the US Food and Drug Administration (FDA) for the JuggerStitch meniscal repair device. This pioneering technology, the next generation of meniscus repair tools, has received 510(k) clearance and is now available in the US market. The distinct design of the JuggerStitch implant incorporates two soft anchors linked by a knotless, self-locking suture loop. This innovation is intended to enhance tissue preservation and grant surgeons greater control over tissue compression at the repair site compared to implants employing a sliding knot to secure the repair.

Additionally, in June 2020, Arcuro Medical secured approval from the US FDA for its SuperBall meniscus repair system.

Meniscus Tear Treatment Market

Treating a torn meniscus typically commences with conservative approaches, considering factors like the tear's type, size, and location. Many meniscus tears might not necessitate immediate surgical intervention. When symptoms are absent, persist for a short duration, and there's no knee locking or swelling, non-operative treatments are advised. These treatments encompass the RICE protocol, known for its effectiveness in most sports-related injuries, which stands for Rest, Ice, Compression, and Elevation. Pain and swelling reduction can be achieved through nonsteroidal anti-inflammatory medications like aspirin or ibuprofen. Steroid injections are also administered to alleviate pain and swelling. Additionally, ongoing research is exploring biologics injections, such as platelet-rich plasma, which hold potential for treating meniscus tears in the future. If symptoms persist despite nonsurgical interventions, arthroscopic surgery becomes a recommended option.

Meniscus Tear Market Report Features

Geography Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

Study Period: 2019-2032

Meniscus Tear Market Size: USD XX million in 2032

Key Meniscus Tear Companies: Smith & Nephew, Arcuro Medical, Zimmer Biomet Holdings, and others.

Leading Meniscus Tear Companies and Emerging Drugs: Pioneering companies such as Smith & Nephew, Arcuro Medical, Zimmer Biomet Holdings, among others, are actively developing novel drugs for potential entry into the Meniscus Tear market.

Meniscus Tear Therapeutic Landscape: Medical Devices identified for Meniscus Tear treatment include NOVOSTITCH PRO Meniscal Repair System, JuggarStitch, SuperBall meniscus repair system, and more.

Meniscus Tear Overview:

A meniscus tear refers to damage or a tear occurring in the meniscus, a piece of cartilage that acts as a cushion and stabilizer between the bones in the knee joint. These tears often happen due to twisting or sudden movements, particularly during sports activities or as a result of aging and degeneration.

Meniscus Tear Symptoms: Individuals with a meniscus tear may experience pain, swelling, stiffness, and difficulty moving the knee joint. There might be a sensation of catching or locking within the knee during movement.

Meniscus Tear Causes: Meniscus tears can result from traumatic injuries, such as sudden twists or impact during sports, or degenerative changes as part of the aging process, where the cartilage weakens over time.

Meniscus Tear Types: Tears in the meniscus can vary in severity and pattern. Common types include longitudinal tears (tears along the length of the meniscus), radial tears (tears that extend from the inner to the outer edge), and bucket-handle tears (a large, significant tear that can displace the meniscus).

Meniscus Tear Diagnosis: Healthcare providers diagnose a meniscus tear through physical examination, evaluating symptoms, and may use imaging tests such as MRI or ultrasound to confirm the diagnosis and assess the extent of the tear.

Meniscus Tear Treatment: The treatment approach depends on the type, size, and location of the tear, as well as the individual's activity level and overall health. Options may include:

• Nonsurgical Treatment: Rest, ice, compression, and elevation (RICE protocol), along with physical therapy and anti-inflammatory medications, are often used initially.
• Surgical Repair: For certain types of tears, especially in younger patients or specific tear patterns, surgery might be recommended. This could involve meniscus repair (stitching the torn edges together), meniscectomy (removing the torn portion), or in some cases, meniscus transplant.

Key Facts Meniscus Tear Market Report:

• Key players such as Smith & Nephew, Arcuro Medical, Zimmer Biomet Holdings, and others are investigating its candidates for Meniscus Tear.
• Meniscus Tear pipeline includes devices such as NOVOSTITCH PRO Meniscal Repair System, JuggarStitch, SuperBall meniscus repair system, and others.
• Owing to the positive outcomes of some of the candidates that are the major key players in the meniscus repair systems market are Zimmer Biomet, Smith & Nephew, Arcuro Medical and others. Top manufacturers are developing with advanced expertise with integrated technology.
• Meniscal injuries affecting the knee are prevalent, occurring at a rate of 61 cases per 100,000 individuals, with a prevalence ranging between 12% to 14%. The likelihood of meniscal tears rises notably when there's an accompanying anterior cruciate ligament (ACL) injury, varying between 22% to 86%. In the United States, among an estimated 850,000 cases annually, approximately 10% to 20% of orthopedic surgeries involve surgical meniscus repair. The highest occurrence of acute meniscal tears is observed in men aged 21 to 30 and in women aged 11 to 19. The ratio of men to women affected ranges from 2.5:1 to 4:1. Conversely, degenerative meniscal tears are more frequent in men aged 40 to 60 years.

Meniscus Tear Epidemiology Segmentation:

“Through various secondary studies, it can be concluded that Meniscus Tear is more common among males than females.”

The meniscus weakens with age. Tears are more common in people over the age of 30.

• According to the study conducted by Baker et al. (2018) titled “What is the prevalence of meniscus injuriesin the US?,” the prevalence of acute meniscal tears is 61 cases per 100,000 persons. The overall male-tofemale incidence is approximately 2.5:1. The peak incidence of meniscal injury for males is in those aged 31-40 years. For females, the peak incidence is in those aged 11-20 years. In patients older than 65 years, therate of degenerative meniscal tears is 60%.

The Meniscus Tear market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

• Total Prevalence of Meniscus Tear

• Gender-specific Prevalence of Meniscus Tear

• Type-specific Prevalence of Meniscus Tear

• Age-specific Prevalence of Meniscus Tear

• Diagnosed Cases of Meniscus Tear

DelveInsight's comprehensive report provides a thorough exploration of the Meniscus Tear market, covering key Meniscus Tear players, emerging Meniscus Tear therapies, treatment dynamics, and market challenges.

For in-depth insights, access the full report @ Meniscus Tear Market Outlook 2032

Meniscus Tears Emerging Therapy Assessment

The dynamics of the Meniscus Tear market is anticipated to change in the coming years owing to the improvement in theresearch and development. The launch of devices is expected during the forecast period of 2021–2030.

Ceterix Orthopaedics now acquired by Smith & Nephew, completed the STITCH (A Prospective, Non-randomized, Multi-CenterInvestigation of All-suture-based Repair of Horizontal Meniscal Tears), the first-ever prospective multicenter investigation ofsuture-based repair for patients with horizontal meniscus tears, a common type of knee injury. The trial was last updated inDecember 2020 on clinicaltrial.gov. In March 2021, the company declared positive result wherein twenty-three patients had 2-year follow-up data available. Freedom from reoperation was 96.0% at 6 months (26/27, 91.7% at 1 year [23/25], and 82.6% at2 years [19/23]). Significant improvement was observed in over baseline at 2 years for IKDC (36.7-82.5; P< .001), Knee injuryand Osteoarthritis Outcome Score (52.2-89.3; P < .001), Lysholm (50.2-87.4; P < .001), and Tegner scores (3.3-5.3;P= .007).Minimal clinically important difference was met or exceeded for IKDC and Lysholm scores at 1 year 69.2% and 65.4% ofpatients, respectively. Four patients (6.7%) experienced serious complications, of which 2 were assessed as being related to theprocedure.

Ortho Regenerative Technologies is working on RESTORE-M which will be targeting predominantly to expand the number ofprocedures which involve repair, at the expense of meniscectomy procedures. There is no required change to the surgicaltechnique or procedure, but that the Ortho-M product is placed into the lesion prior to being repaired with whatever physicalfixation is indicated. The company anticipate to complete the preclinical findings by 2021 and initiate the Phase I/II trial by2022-2023 respectively.

DelveInsight's report offers comprehensive insights, market analysis, and forecasts aiding leading companies in strategic decision-making for the Meniscus Tear market landscape.

• Gain Competitive Edge in Indication Market : Understand the current landscape of the Meniscus Tear market, including the competitive environment, key companies developing drugs for Meniscus Tear , and their strategies. By analyzing market dynamics, treatment approaches, and emerging therapies, stakeholders can identify opportunities to position themselves effectively, gaining a competitive edge over others.
• Identify Market Gaps and indication market opportunities : Analyzing epidemiological trends, country wise patient journeys and existing tretment practices can helps in identifying gaps and opportunities within the Meniscus Tear market. This involves recognizing areas where current treatments may be insufficient or where there is an unmet need. The report is curated by taking account of various KOLs dealing with Meniscus Tear. Identifying these gaps allows stakeholders to explore new therapeutic avenues, potentially leading to the development of novel treatments that address specific market needs and price their emerging products strategically to gain a competitive edge.
• Strategic decision making : Armed with insights from epidemiological and market forecasts, stakeholders can make informed and strategic decisions. This may involve deciding on research and development investments, portfolio expansion, pricing - reimbursement strategies, partnerships, or other strategic moves. Understanding the market dynamics enables stakeholders to align their goals with the prevailing trends and future projections.
• Plan RoadMap to Success : Through this report the leading companies can set short-term and long-term goals, define strategies for market penetration, and outline steps for product development or market expansion. A well-informed roadmap ensures that stakeholders navigate the complexities of the Meniscus Tear market with clarity and purpose.

Related Reports:

Meniscus Tear Epidemiology Forecast

Meniscus Tear Epidemiology Forecast report delivers an in-depth understanding of the Meniscus Tear, historical and forecasted epidemiology in the United States, the EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Meniscus Tear Pipeline Insight

Meniscus Tear Pipeline Insight report provides comprehensive insights about companies and pipeline drugs in the Meniscus Tear pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. 

Healthcare Consulting and Market Research Services by DelveInsight

Discover how DelveInsight’s comprehensive analysis and proactive strategies facilitated a US-based pharmaceutical client’s triumphant entry into the European biosimilar landscape. Download Pharma Go-to-Market Case Study.

Trending Reports by DelveInsight

Functional Constipation Market

https://www.delveinsight.com/report-store/chronic-constipation-market

Lebers Hereditary Optic Neuropathy Lhon Market

https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market

Gastric Neuroendocrine Tumors Market

https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market

Immune Thrombocytopenic Purpura Market

https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market

Visceral Pain Associated With GI Disorders Market

https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market

Bullous Pemphigoid Market

https://www.delveinsight.com/report-store/bullous-pemphigoid-market

Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market

Myocarditis Market

https://www.delveinsight.com/report-store/myocarditis-market

Recurrent Blood Clots Market

https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market

Zollinger-ellison Syndrome Market

https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market

Age-related Hearing Loss Medical Device Market

https://www.delveinsight.com/blog/age-related-hearing-loss-device-market

Heart Sounds Sensors Market

https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market

Hypoplastic Left Heart Syndrome Hlhs Market

https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market

Infectious Arthritis/Septic Arthritis Market

https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market

Plasmacytoma Market

https://www.delveinsight.com/report-store/plasmacytoma-market

Agoraphobia Market

https://www.delveinsight.com/report-store/agoraphobia-market

Clinically Isolated Syndrome CIS Market

https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market

Fucosidosis Market

https://www.delveinsight.com/report-store/fucosidosis-market

Major Depressive Disorder Market

https://www.delveinsight.com/report-store/major-depressive-disorder-market

Neuronal Ceroid-lipofuscinoses Market

https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market

Orthotic Devices Market

https://www.delveinsight.com/report-store/orthotic-devices-market

About DelveInsight:

DelveInsight is a prominent business consultant and market research firm specializing in the life sciences sector. With a focus on supporting pharmaceutical companies, DelveInsight provides end-to-end solutions to enhance their performance.

Connect with DelveInsight:

LinkedIn | Facebook | Twitter

Contact Us:

Kritika Rehani

Team Lead, Marketing

krehani@delveinsight.com

+91-9650213330

www.delveinsight.com